Intrexon (XON) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Wall St futures rise as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- HubSpot to cut 7% of workforce in restructuring plan
- Nasdaq notches record high close as investors focus on earnings
- Francis Halzen wins Nobel Physics Prize for Antarctic 'ghost particle' hunt
Ziopharm Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 10, 2018 4:01 PM EDT-Â Â Expanding Controlled IL-12 platform to explore additional tumor types
-Â Â Cash runway extended to 2Q 2019 with changes to Controlled IL-12 development plans
-Â Â ASCO poster to detail IL-12 data in breast cancer, glioblastoma, highlight potential for combination with checkpoint inhibitors
-Â Â Sleeping Beauty CAR-T cells manufactured in two days entering clinic in 2H
-Â Â Company to host conference call today at 4:30 p.m. ET
BOSTON, May 10, 2018 (GLOBE NEWSWIRE) --... More



